Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen†
Abstract
Rhamnose and sTn antigen were co-conjugated to bovine serum albumin (BSA), a weakly immunogenic carrier protein, for cancer vaccine development. The immune responses against sTn have been significantly augmented with the involvement of Rha-specific antibodies to enhance antigen uptake.